Angeles Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.96M Buy
20,301
+1,310
+7% +$305K 0.27% 41
2025
Q4
$3.93M Buy
18,991
+3,170
+20% +$627K 0.22% 47
2025
Q3
$2.93M Buy
15,821
+745
+5% +$128K 0.18% 49
2025
Q2
$2.3M Sell
15,076
-1,317
-8% -$202K 0.16% 53
2025
Q1
$2.72M Buy
16,393
+227
+1% +$35.5K 0.23% 45
2024
Q4
$2.34M Buy
16,166
+329
+2% +$51K 0.19% 47
2024
Q3
$2.57M Buy
15,837
+2,877
+22% +$458K 0.22% 43
2024
Q2
$1.89M Sell
12,960
-1,097
-8% -$163K 0.18% 49
2024
Q1
$2.22M Sell
14,057
-745
-5% -$119K 0.22% 43
2023
Q4
$2.32M Buy
14,802
+2,436
+20% +$374K 0.28% 36
2023
Q3
$1.93M Buy
12,366
+379
+3% +$62.5K 0.27% 38
2023
Q2
$1.98M Buy
11,987
+912
+8% +$147K 0.27% 42
2023
Q1
$1.72M Sell
11,075
-1,021
-8% -$165K 0.26% 47
2022
Q4
$2.14M Buy
12,096
+698
+6% +$121K 0.37% 36
2022
Q3
$1.86M Sell
11,398
-273
-2% -$46.2K 0.37% 33
2022
Q2
$2.07M Buy
11,671
+2
+0% +$356 0.41% 32
2022
Q1
$2.07M Buy
+11,669
New +$1.99M 0.39% 29

Other funds holding JNJ

Angeles Wealth Management's JNJ Position: Q1 2026 in Review

Angeles Wealth Management increased its Johnson & Johnson (JNJ) stake by 6.9% in Q1 2026, buying an estimated $305K and bringing the position to 20,301 shares worth $4.96M. The position accounts for 0.27% of the portfolio, ranked #41.

Angeles Wealth Management first reported a position in JNJ in Q1 2022 and has held it in 17 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Angeles Wealth Management held 20,301 shares of Johnson & Johnson worth $4.96M as of Q1 2026.
  • Angeles Wealth Management bought 1,310 Johnson & Johnson shares in Q1 2026, an estimated $305K.
  • Johnson & Johnson made up 0.27% of Angeles Wealth Management's portfolio in Q1 2026, its #41 holding.
  • Angeles Wealth Management first reported a position in Johnson & Johnson in Q1 2022 and has held it in 17 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Angeles Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.